Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSC-Derived Exosome for Moderate to Severe Erectile Dysfunction
NCT07319533Phase 2Not yet recruiting
- Sponsor
- Labbafinejad Medical Center
- Start
- Jan 2026
- Primary completion
- Jan 2027
- Modality
- Lipid-based Nanoparticles, Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cell-derived exosomes in erectile dysfunction (ED), sponsored by Labbafinejad Medical Center. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
human umbilical cord mesenchymal stem cell-derived exosomes
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT07319533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07319533.